A research team from HKUMed developed thyroid hormone (TH)-encapsulated nanoparticles that selectively target adipose tissues, reducing obesity-related metabolic complications and atherosclerosis. The treatment converts 'bad' white fat to 'good' brown fat, burning calories and alleviating hypercholesterolemia.
SourceThe University of Hong Kong·JournalNature Communications·TypeExperimental study·DateMar 12, 2023
Researchers at University of Technology Sydney have successfully created personalized 'bio-inks' from patients' own stem cells, which are then used to 3D-print cardiac tissues to repair areas of dead tissue. This technology shows promise in treating heart failure and may reduce the need for expensive and traumatic heart transplants.
SourceUniversity of Technology Sydney·JournalBioprinting·TypeExperimental study·DateMar 12, 2023
Researchers at Garvan Institute of Medical Research found that introducing bacteria to a tumor's microenvironment triggers an immune response, activating neutrophils to destroy tumors in animal models. This breakthrough therapy targets neutrophils to improve cancer treatment outcomes.
SourceGarvan Institute of Medical Research·JournalCancer Research·TypeExperimental study·DateMar 12, 2023
Researchers from Kumamoto University found that synchronizing ovulation and mating in
SourceKumamoto University·JournalPLOS ONE·TypeExperimental study·DateMar 12, 2023
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
A recent study published in PNAS reveals that the protein TSKS plays a crucial role in eliminating sperm cytoplasm, enabling a streamlined structure necessary for successful fertilization. The findings suggest potential applications for diagnostic tests and male contraceptives.
SourceOsaka University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMar 12, 2023
A new device developed by quantum engineers can measure the spins in materials with high precision, breaking the current record of thousands of spins. This breakthrough enables researchers to study systems that were previously inaccessible, such as microscopic samples and two-dimensional materials.
SourceUniversity of New South Wales·JournalScience Advances·TypeExperimental study·DateMar 12, 2023
A phase two trial found that exenatide significantly reduced brain pressure and monthly headaches in seven patients with Idiopathic Intercranial Hypertension (IIH). The study showed a rapid action of the drug, with results indicating significant reductions in brain pressure and headache days compared to the placebo arm.
SourceUniversity of Birmingham·JournalBrain·TypeRandomized controlled/clinical trial·DateMar 12, 2023